Arcus Biosciences
Price & Volume
Stats
See more52W Range | $10.25-$31.73 |
Market Cap | $4B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $117M |
Revenue Growth (YoY) | -74.4% |
Gross Profit (12 Mos) | -$380M |
Diluted EPS | -$4.13 |
News
See moreYahoo Finance • 3 days ago
Biotech Breakout: What's in focus after Moderna's cancer win?
Yahoo Finance • 3 months ago
How Eisai (TSE:4523) Is Reframing Its Story With A Tweaked Fair Value Outlook
Yahoo Finance • 4 months ago
Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer
Yahoo Finance • 4 months ago
Gilead’s Arcus Pullback and Idvynso HIV Challenge Might Change The Case For Investing In GILD
About
CEO | Dr. Terry J. Rosen Ph.D. |
CFO | Mr. Robert C. Goeltz II |
Address | 3928 Point Eden Way, Hayward, CA, United States, 94545 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 601 |